RxDoctor Payments Data

Samita Das

Pain Medicine · Baton Rouge, LANPI 1487092920

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $7,353 of the $9,554 with a category attached, or 77.0%. It is spread thinly across 22 manufacturers, the largest accounting for just 21.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $2,475 and has fallen 64.4% since, to $880 in 2025.

$9,554in general payments, 2019–2025

Across 185 payments — averaging $51.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$2K
  • Abbott$2K
  • Medtronic$2K
  • Relievant Medsystems, Inc.$1K
  • Nevro Corp.$393
  • SPR Therapeutics, Inc$281
  • plus $2K from 16 others

What the payments were for

  • Travel & lodging$2,20123%
  • Food & beverage$7,35377%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,554 in reported general payments places this provider in the 80th percentile of 97 pain medicine providers in Louisiana.

See all pain medicine providers in Louisiana

Medicare billing

Part B allowed, 2024
$59,853
Medicare patients
138
Services billed
591

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin366$5,871
Pregabalin292$5,269
Methocarbamol67$1,159
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen73$1,130
Tizanidine Hcl80$969
Amitriptyline Hcl35$548
Diclofenac Sodium18$445
Topiramate39$414
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen30$344
Duloxetine Hcl19$332
Nabumetone23$302
Tramadol Hcl47$168
Cyclobenzaprine Hcl23$164
Methylprednisolone22$132
Meloxicam17$63

Paid to pharmacies, not to this prescriber.

Other pain medicine in Baton Rouge

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →